Studying Biomarkers in Patients With Pancreatic Cancer
Completed
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Studying samples of tissue in the laboratory from patients with cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients with pancreatic cancer.
Key facts
- Study ID
- NCT00900003
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 53
- Starts
- 2007-05-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2013-12-12
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Any subject with excess tissue collected at time of routine surgery for pancreatic cancer is eligible.
- All subjects participating in this protocol will be followed for recurrence, relapse and death from disease
Where it is running
- Vanderbilt-Ingram Cancer Center - Cool Springs — Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin — Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.